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Background: Identification of factors associated with work disability in cancer survivors on long term sick leave
may support these survivors in choosing effective measures to facilitate vocational rehabilitation and return to work.
Therefore, this study aims to disclose factors associated with work disability in cancer survivors at 24 months of sick
leave.
Methods: A cross sectional study was conducted. The study population consisted of employed sick-listed cancer
survivors, aged between 18 and 64 years. They received a questionnaire at 24-month sick leave, the maximum
period of sick leave allowed by Dutch social security legislation. Data were linked with the outcome of work
disability assessment, as performed by the Dutch social security agency. A hierarchical multivariate logistic
regression analysis was performed to identify factors associated with work disability.
Results: Data of 351 valid cases were analysed. The multivariate analysis showed that, for cancer survivors at
24-month sick leave, Dutch nationality, higher education, receiving hormone therapy, metastatic disease, physical
limitations and low self-reported work ability were associated with an increased risk for work disability.
Conclusions: This study identified factors associated with work disability of employed cancer survivors at
24 months of sick leave. The results of the current study may serve as a starting point to investigate the course of
work disability beyond the maximum period of 24 months of sick leave. In order to enhance work participation of
cancer survivors beyond this term, prospective data on work disability in the Netherlands are required.
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In the last decade, work participation of cancer survivors
has received growing attention worldwide [1]. Previous
studies have shown that cancer survivors are at risk for
job loss, unemployment and work disability [2-9]. Cancer
survivors who are unable to resume a former job not only
face the risk of a financial loss [10]. That is, job loss can
have a negative effect on recovery as well [11]. Return to
work (RTW) may help cancer survivors to regain control,
lead the way back to the former normal life, strengthen
their self-confidence and support them to overcome nega-
tive side-effects of treatment [12,13]. Also, enhancement* Correspondence: p.vanmuijen@vumc.nl
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article, unless otherwise stated.of work participation of cancer survivors is to the advan-
tage of society at large, in reducing the costs of sick leave
and work disability benefits, as well as productivity loss
[14]. Therefore, the prevention of work disability in cancer
survivors needs ongoing attention.
The impact of cancer and the potential side-effects of
the treatment can lead to functional limitations, physical
and/or psychological disabilities. This may create a bar-
rier to work participation [15-17]. For instance, func-
tional limitations leading to job changes or even exit
from work were reported by 11% of breast cancer survi-
vors in a study by Peuckmann et al. [18]. Further, in a
cohort of male and female cancer survivors (mixed diag-
noses), 27% of men and 32% of women reported work
disabilities [7]. Also, in a cohort of cancer survivors
(mixed diagnoses) with follow-up lasting between one to
five years, 20% of respondents reported cancer-relatedtral Ltd. This is an Open Access article distributed under the terms of the
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, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
van Muijen et al. BMC Cancer 2014, 14:236 Page 2 of 10
http://www.biomedcentral.com/1471-2407/14/236disabilities and only half of those reporting disabilities
were able to work [19]. Functional limitations and re-
duced work productivity can last up to several years
after diagnosis, as reported by Yabroff. In this study,
significant differences between cancer survivors and
matched controls were found [20].
A number of factors negatively associated with work
participation of cancer survivors have been identified.
These factors are related to socio-demographics (e.g., old
age, low education, low income), the disease (e.g., tumor
site, chemotherapy, advanced tumor stage) and work-re-
lated characteristics (e.g., physical work demands) [1,15].
Still, the need to disclose unidentified factors associated
with work participation of cancer survivors remains. That
is, factors associated with work disability of cancer sur-
vivors present at a 24-month sick leave term, are poorly
investigated. Most studies focus on RTW, are either based
on hospital data or data of an occupational health service
and relate to a period of absence from work of three up to
18 months [21,22]. During this period, relatively shortly
after diagnosis, potential long-term sequelae of cancer and
cancer treatment, possibly associated with work disability,
may not be apparent.
Recently, a number of factors associated with work
disability assessment outcomes were identified. That is,
in a prospective study it was reported that at 10-month
sick leave, perception of health care providers on can-
cer survivors’ work ability and experienced influence on
RTW, both reported by workers, were significantly asso-
ciated with the level of work disability at 24 months
[23]. As factors at 10-month sick leave exert an influence
on work disability at 24 months, this questions what
factors are associated with sustained work disability as
assessed at 24-month sick leave and beyond. Identifica-
tion of barriers of work participation, i.e., factors asso-
ciated with work disability at specific points in time, can
make it possible to offer the adequate support, using re-
sources in an optimal way. Therefore, this study aims to
identify factors associated with the level of work dis-
ability at 24-month sick leave in cancer survivors. Here-
with, the level of work disability is defined as wage loss
related to functional limitations, which is present prac-
tice in the Dutch social security system.
Methods
Design
A cross-sectional design was used for the current study,
for which two data sources were used: 1) questionnaire
data, and 2) register data of work disability assessments.
The period of inclusion started in July 2011 and ended
in February 2012. Data were collected when study par-
ticipants approached the maximum term of 24-month
sick leave and applied for a work disability benefit at the
Dutch Social Security Agency (SSA). In the Netherlands,the SSA is responsible for the assessment of work dis-
ability of workers on long-term sick leave. The assess-
ment of functional abilities at 24-month sick leave (the
maximum period allowed by law) is done by an insu-
rance physician. If applicable, based on the physician’s
report, a labour expert calculates the loss of former
wages earned. In 2009, 65% of Dutch cancer survivors
who applied for a work disability benefit was granted a
full work disability benefit [24]. This implies a wage loss
of ≥ 80% of former wages earned.
Questionnaires were sent to the participants at their
home address. Upon receipt, data of the questionnaires
were linked to SSA data. The study was approved by the
Medical Ethics Committee of the VU University Medical
Center.
Study population
The study population consisted of sick-listed employed
workers (hereafter designated as workers) who were regis-
tered at the SSA. They were aged between 18 and 64 years.
All workers had a reported diagnosis of cancer, and were
approaching a sick leave term of 24 months. Diagnosis
had to be confirmed within the first six months of sick
leave. Workers were excluded if they received active
chemotherapy and/or radiotherapy treatment, if they had
a previous diagnosis of cancer but applied for a work
disability benefit due to another somatic or psychiatric
disorder, if they were self-employed, if they were applying
for a revision of a previous work disability assessment, or
if they were employed in a so-called sheltered workplace.
Study procedure
Potentially eligible participants of our study were se-
lected at the head office of the SSA. During the period
of inclusion, the list of new work disability benefit appli-
cations was checked by one author (KBG or PvM) every
week. Based on this list of social security numbers and
corresponding documents, we selected the sick-listed
workers with a diagnosis of cancer, as reported in the at-
tached medical records. After starting the selection, in
case of doubt, cases were included based on consensus.
Potentially eligible participants received a questionnaire,
an informed consent form, and information stating the
aim and background of the study. A postage-paid return
envelope (to the Research Center for Insurance Me-
dicine at the EMGO + Institute at the VU University
Medical Center) and an introductory letter, by the chief
medical officer of the SSA, were added. This letter stated
the independency of the researchers and stressed that
participation would be of no influence on the outcome
of the work disability assessment. Participants had to
complete the informed consent form by hand and affix a
signature. On receipt of the signed informed consent
form and the questionnaire, we linked the latter with
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collected at the SSA head office, and entered these data
in a secured database. The chief medical officer of the
SSA gave permission to access the SSA’s registry data. A
reminder was sent after two weeks. Also, a reminder was
sent in case of a missing signature on the informed con-
sent form. Questionnaires of respondents lacking a com-
pleted form were destroyed. All respondents received a
gift voucher.
Workers who reported to receive chemotherapy and/or
radiotherapy and workers of whom the main reason for
application was not cancer-related, were excluded. They
were sent a letter explaining the reason of exclusion. The
questionnaires were checked for completeness and, if
necessary, respondents were contacted to supply missing
data.Variables
The independent and dependent variables were collected
through questionnaires as used in earlier studies on cancer
survivorship and return to work [1,11,25-27].Independent variables
Socio-demographics
The following socio-demographic characteristics were de-
termined: (a) age (in years), (b) gender (male; female), (c)
marital status (single; married/living with partner; divorced/
widowed), (d) number of children, (e) principal wage ear-
ner (yes; no), (f) educational level (no education/primary
school/lower vocational education; secondary school; voca-
tional education/upper secondary school; upper vocational
education/university), (g) nationality (Dutch; non-Dutch).Health determinants
The following health characteristics were assessed: (a)
tumor type, (b) extensive disease (negative lymph nodes;
positive lymph nodes; metastasis), (c) treatment moda-
lities (surgery; radiotherapy; chemotherapy; hormone
therapy; bone marrow transplant; immunotherapy), (d)
being free of disease (yes; no; don’t know), (e) co-
morbidity (number of additional diseases). Physical
symptom burden was measured using (f ) the physical
dimension score of the Sickness Impact Profile (SIP),
covering three scales, i.e., Body Care and Movement,
Ambulation, and Mobility [28]. Also, (g) fatigue, (h) de-
pressive mood, and (i) global health were measured
using the Functional Assessment of Chronic Illness
Therapy-Fatigue Scale (FACIT-F) [29], the Center for
Epidemiologic Studies Depression Scale (CES-D) [30],
and the European Organisation for Research and Treat-
ment of Cancer Quality of Life Questionnaire-C30
(EORTC-QLQ-C30) [31], respectively.Work-related determinants
The following characteristics of the previous job held were
determined: (a) type of job (white collar; civil servant; blue
collar; health care worker), (b) job tenure (in years),
(c) working hours (hours/week), (d) shift work (yes; no),
(e) managerial tasks (yes; no), (f) number of supervised
co-workers, (g) work demands (psychological; physical;
both), (h) company size (number of employees), and (i)
work ability expectations (same; increase; decrease; don’t
know). Related to the present (j) work status (working; not
working), (k) the actual number of working hours were
determined. Finally, with the first three items of the Work
Ability Index (WAI) [1] current work ability compared to
life time best, (m) current work ability related to physical
work demands and (n) current work ability related to
psychological work demands, were measured [32].
Dependent variable
The primary outcome variable was the level of work dis-
ability after 24 months of sick leave. This was operationa-
lised by dichotomising the results of the work disability
assessments, the entitlement for work disability compen-
sation, as performed by the SSA. In the Netherlands, the
level of work disability is assigned to one out of four ca-
tegories, depending on wage loss or sustainable absence
of functional abilities. If functional abilities are assessed
present, wage loss can be either (1) less than 35%, (2) in
between 35 to 80%, or (3) over 80% of former wages
earned. The compensation granted can be none, partial,
or complete, respectively. If a person has no labour capaci-
ties (sustainable absence of functional abilities) the clai-
mant is granted (4) a compensation by the Benefit Act for
the fully and sustained work disabled. The participants
with a wage loss of less than 80% were grouped together,
as well as those with a wage loss equal to or more than
80% and those with a permanent and sustainable work
disability. Herewith, workers assessed as still being able
to earn an income were distinguished from those un-
able to earn an income, i.e., incomplete versus complete
work disability.
Statistical analysis
The following variables were binominal: gender, natio-
nality, work status, principal wage earner, shift work,
managerial tasks, and treatment modalities. A number
of variables was dichotomized: age, job tenure, working
hours per week in previous job, the number of super-
vised co-workers, working hours per week in present
job, scores of the SIP, FACIT-F, EORTC-QLQ-C30, and
WAI, using the median as a cut-off point. For the CES-
D, the variable was dichotomized at a score of 16, the
predetermined cut-off point most often used for likely
cases of clinical depression [30]. Categorical variables
were marital status, number of children, education, type
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type, extensive disease, and being free of disease.
The association between independent variables and
the binominal level of work disability at 24 months
(wage loss <80%; ≥80%) were analysed with univariate
and multivariate methods. For univariate analysis, a Chi-
square test was performed using a cut-off for p-values of
0.20. The remaining significant independent variables of
univariate analysis were then tested for multicollinearity
and accepted in a logistic regression model if correlation
coefficients were ≥ −0.6 and ≤0.6 [33]. Next, for each cat-
egory of variables, i.e., socio-demographics, work-related
characteristics and health characteristics, multiple logis-
tic regression analysis was performed, using a backward
stepwise method. For each category of variables, this
resulted in a logistic regression model presenting va-
riables associated with work disability at 24 months of
sick leave. Next, using the results of these three back-
ward stepwise models a final model was built. In this
final model, variables of the three categories i.e. socio-
demographics, health determinants and work-related
determinants were added in consecutive order. This re-
sulted in a final model, presenting variables associated
with work disability at 24 months of sick leave, control-
ling in a hierarchical way for socio-demographics, health
determinants and work-related determinants. The asso-
ciation for each independent variable and the level of
work disability at 24 months was calculated using odds
ratios (OR). In the logistic regression analyses, a cut-off
for p-values of 0.1 (Wald statistics) for independent vari-
ables was chosen. The Hosmer-Lemeshow test was used
to assess the goodness of fit. All analyses were per-
formed using SPSS 20 [34].
Results
Characteristics of the study population
During the period of inclusion, 13,023 employed workers
applied for a work disability benefit. Of these 1,307 had
a diagnosis of cancer of whom 995 met the inclusion cri-
teria. These 995 workers were sent a questionnaire, of
whom 528 responded. Based on exclusion criteria (i.e.,
data retrieved from received questionnaires) and based
on supplementary SSA data, 136 of the respondents
were excluded. Finally, 392 cancer survivors were in-
cluded. In 41 of the 392 cancer survivors, the level of
work disability could not be retrieved, leaving 351 valid
cases. The mean age of these respondents was 51.1 years
(SD 7.4 years) and 36% were men. The majority (79%)
was in a relationship and 27% was educated at high
vocational or university level. Related to the category
health determinants, more specifically tumor type, breast
cancer was reported in 40%, haematological cancer in
14%, and cancer of the digestive system in 13% of the
cases. Other tumor types were reported in 33% of cancersurvivors. Related to extensiveness of disease, 52% of re-
spondents reported having negative lymph nodes and
42% reported being free of disease. In the category
work-related determinants, 40% of respondents worked
in a blue collar job and 29% in a white collar job. A total
of 60% of the respondents reported their company to
have > 100 employees, and 40% reported to be actually
working in paid labour. Positive work ability expecta-
tions were reported by 35% respondents, and 17% ex-
pected work ability to stay the same.
Level of work disability
Regarding the dependent variable, we found that of the
351 cancer survivors, 92 had less than 35%, 101 between
35 and 80%, and 97 over 80% loss of former wages
earned, as assessed by the SSA at 24-month sick leave.
In 61 of the cancer survivors, no labour capacities (full
and sustained work disability) were present.
Cancer survivors and determinants of work disability
Results of the univariate analyses, in which the relation-
ship between the independent variables and the level of
work disability at 24-month sick leave were tested, are
presented in Tables 1 and 2. In the multivariate analyses,
all variables that showed a p-value of <0.2 in the univa-
riate analyses (n = 21) were used to build a final multi-
variate model. The backward stepwise analyses showed
associations at a level of p < 0.1 for nationality, educa-
tion, extensive disease, hormone therapy, being free of
disease, the physical dimension score (SIP), global
health (EORTC-QLQ-C30 score), work demands, and
current work ability compared to life time best score
(WAI). These nine variables were entered in the hier-
archical model in consecutive order as listed above. The
last (ninth) step of the hierarchical multivariate analyses
is presented in Table 3. The Hosmer-Lemeshow test re-
vealed that this model had a good fit (p = 0.948). In this
final model, we found associations at a level of p < 0.1
for nationality, education, hormone therapy, extensive
disease, the physical dimension score (SIP), and current
work ability compared to life time best score (WAI).
Specifically, cancer survivors of non-Dutch nationality
were less at risk for work disability than their Dutch
counterparts (OR 0.15; CI 0.02-0.95); an education at
the level of secondary school (OR 4.80; CI 1.72-13.42)
and vocational education/upper secondary school (OR
2.78; CI 1.16-6.69) were both associated with an in-
creased risk for work disability when compared to the
lowest educational category. Further, receiving hormone
therapy (OR 2.20; CI 1.08-4.47), having metastatic dis-
ease (OR 4.51; CI 1.65-12.34) and reporting a high level
of physical complaints (SIP) (OR 2.62; CI 1.34-5.14)
were all associated with an increased risk for work dis-
ability. A high score on current work ability compared
Table 1 Characteristics of employed cancer survivors*
Socio-demographics Categories n (%) Disability (<80%; ≥80%) p-value
n (%); n (%)
Gender Male 125 (36) 68 (54); 57 (46) 0.870
Female 226 (64) 125 (55); 101 (45)
Age in years < 52 163 (46) 98 (60); 65 (40) 0.072
≥ 52 188 (54) 95 (50); 93 (50)
Marital status Single 35 (10) 22 (63); 13 (37) 0.413
Married/living with partner 278 (79) 153 (55); 125 (45)
Divorced/widowed 38 (11) 18 (47); 20 (53)
No. of children None 90 (26) 55 (61); 35 (39) 0.576
1 46 (13) 24 (52); 22 (48)
2 139 (40) 75 (54); 64 (46)
> 2 76 (21) 39 (51); 37 (49)
Principal wage earner Yes 193 (55) 109 (56); 84 (44) 0.465
No 156 (45) 82 (53); 74 (47)
Nationality Dutch 340 (97) 184 (54); 156 (46) 0.069
Non-Dutch 11 (3) 9 (82); 2 (18)
Education None/ primary/lower vocational 91 (26) 49 (54); 42 (46) 0.102
Secondary school 60 (17) 25 (42); 35 (58)
Vocat. education/upper sec. school 105 (30) 63 (60); 42 (40)
Upper vocat. education/university 94 (27) 56 (60); 38 (40)
Health determinants
Tumor type Mamma 143 (40) 93 (65); 50 (35) 0.024
Urinary tract 20 (6) 11 (55); 9 (45)
Urogenital (m) 11 (3) 5 (46); 6 (54)
Urogenital (f) 17 (5) 10 (59); 7 (41)
Respiratory tract 24 (7) 6 (25); 18 (75)
Digestive system 45 (13) 21 (47); 24 (53)
Head and neck 18 (5) 12 (67); 6 (33)
Haematological 50 (14) 25 (50); 25 (50)
Central nerve system 10 (3) 4 (40); 6 (60)
Other 13 (4) 6 (42); 7 (58)
Extensive disease Negative lymph nodes 180 (52) 103 (57); 77 (43) 0.001
Positive lymph nodes 116 (34) 72 (62); 44 (38)
Metastasis 50 (14) 16 (32); 34 (68)
Treatment modalities Surgery yes 242 (69) 141 (58); 101 (42) 0.066
no 109 (31) 52 (48); 57 (52)
Radiotherapy yes 210 (60) 114 (54); 96 (46) 0.748
no 141 (40) 79 (56); 62 (44)
Chemotherapy yes 253 (72) 134 (53); 119 (47) 0.221
no 98 (28) 59 (60); 39 (40)
Hormone therapy yes 107 (30) 69 (65); 38 (35) 0.018
no 244 (70) 124 (51); 120 (49)
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Table 1 Characteristics of employed cancer survivors* (Continued)
Bone marrow transplant yes 19 (6) 6 (32); 13 (68) 0.035
no 332 (94) 187 (56); 145 (44)
Immunotherapy yes 31 (9) 18 (58); 13 (42) 0.718
no 320 (91) 175 (55); 145 (45)
Being free of disease Yes 147 (42) 99 (67); 48 (33) 0.000
No 106 ( 31) 42 (40); 64 (60)
Don’t know 94 (27) 48 (51); 46 (49)
Comorbidity No. of additional diseases 0 195 (56) 112 (58); 83 (52) 0.324
No. of additional diseases 1 51 (14) 31 (61); 20 (39)
No. of additional diseases 2 52 (15) 25 (48); 27 (52)
No. of additional diseases≥ 3 53 (15) 25 (47); 28 (53)
Work-related determinants
Type of job White collar 102 (29) 59 (58); 43 (52) 0.459
Civil servant 33 (9) 15 (45); 18 (55)
Blue collar 139 (40) 73 (53); 66 (47)
Health care worker 77 (22) 46 (60); 31 (40)
Job tenure in years ≤ 10 173 (49) 97 (56); 76 (44) 0.687
> 10 178 (51) 96 (54); 82 (46)
Working hours a week ≤ 32 177 (50) 90 (51); 87 (49) 0.116
> 32 174 (50) 103 (59); 71 (41)
Shift work Yes 115 (33) 67 (58); 48 (42) 0.371
No 235 (67) 125 (53); 110 (47)
Managerial tasks Yes 70 (20) 41 (59); 29 (41) 0.488
No 278 (80) 150 (54); 128 (46)
No. of supervised co-workers ≤ 7 35 (50) 18 (51); 17 (49) 0.225
> 7 35 (50) 23 (66); 12 (34)
Work demands Psychological and physical 168 (48) 93 (55); 75 (45) 0.084
Psychological 106 (30) 65 (61); 41 (39)
Physical 76 (22) 34 (45); 42 (55)
Company size No. of employees 1-9 37 (10) 21 (57); 16 (43) 0.379
No. of employees 10-99 104 (30) 51 (49); 53 (51)
No. of employees≥ 100 208 (60) 119 (57); 89 (43)
Work ability expectations Same 40 (17) 36 (90); 4 (10) 0.000
Increase 79 (35) 64 (81); 15 (19)
Decrease 31 (13) 15 (48); 16 (52)
Don’t know 81 (35) 58 (72); 23 (28)
Work status Working 141 (40) 122 (87); 19 (13) 0.000
Not working 210 (60) 71 (34); 139 (66)
Actual working hours per week ≤ 20 79 (56) 64 (81); 15 (19) 0.030
> 20 62 (44) 58 (94); 4 (6)
*Due to missing data n varies (range: 70–351); p-value: result of Chi-square test, univariate associations between independent variables and work disability.
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Table 2 Questionnaire scores of employed cancer survivors
Variables Cut-off value* n (%) Disability (<80%; ≥ 80%) p-value†
n (%); n (%)
Physical dimension score (SIP; 0–100) ≤ 3.77‡ 179 (51) 129 (72); 50 (28) 0.000
> 3.77 172 (49) 64 (37); 108 (63)
Fatigue (FACIT-F; 0–52) ≤ 27§ 173 (49) 73 (42); 100 (58) 0.000
> 27 178 (51) 120 (67); 58 (33)
Depressive mood (CES-D; 0–60) ≤ 16∥ 188 (54) 114 (61); 74 (39) 0.017
> 16 163 (46) 79 (49); 84 (51)
Global health (EORTC-QLQ-C30; 0–100) ≤ 58.33¶ 160 (46) 61 (38); 99 (62) 0.000
> 58.33 191 (54) 132 (69); 59 (31)
Current work ability (WAI; 0–10) ≤ 4** 143 (48) 52 (36); 91 (64) 0.000
> 4 158 (52) 131 (83); 27 (17)
Physical demands (WAI; 0–5) ≤ 3†† 142 (62) 97 (68); 45 (32) 0.003
> 3 86 (38) 74 (86); 12 (14)
Psychological demands (WAI; 0–5) ≤ 3‡‡ 121 (52) 83 (69); 38 (31) 0.021
> 3 110 (48) 90 (82); 20 (18)
*Cut-off value = median (except for CES-D; the predetermined cut-off point is used here); †Result of Chi-square test; Range as reported by participants: ‡0-79.83;
§0-52; ∥0-57; ¶0-100; **0-10; ††1-5; ‡‡1-5.
Table 3 Multivariate associations between independent variables and work disability in employed cancer survivors
Socio-demographics* Categories Odds ratio (95% CI) p-value
Nationality Dutch; non-Dutch 0.147 (0.02-0.95) 0.044
Education 0.015
None/primary/lower vocational education Ref.
Secondary school 4.80 (1.72-13.42) 0.003
Vocational education/upper sec. school 2.78 (1.16-6.69) 0.022
Upper vocational education/university 1.68 (0.65-4.38) 0.286
Health determinants*
Being free of disease 0.358
Yes Ref.
No 1.44 (0.64-3.23) 0.380
Don’t know 1.69 (0.80-3.57) 0.166
Hormone therapy No; yes 2.20 (1.08-4.47) 0.029
Extensive disease 0.013
Negative lymph nodes Ref.
Positive lymph nodes 1.23 (0.60-2.52) 0.582
Metastasis 4.51 (1.65-12.34) 0.003
Physical dimension score (SIP; 0–100) ≤ 3.77; > 3.77† 2.62 (1.34-5.14) 0.005
Global health (EORTC-QLQ-C30; 0–100) ≤ 58.33; > 58.33‡ 0.83 (0.40-1.70) 0.607
Work-related determinants*
Work demands 0.109
Psychological and physical Ref.
Psychological 1.04 (0.50-2.19) 0.913
Physical 2.51 (1.05-6.01) 0.039
Current work ability (WAI; 0–10) ≤ 4; > 4§ 0.09 (0.04-0.19) 0.000
*For binairy variables the reference value is listed first; Range as reported by participants: †0–79.83; ‡0–100; §0–10.
van Muijen et al. BMC Cancer 2014, 14:236 Page 7 of 10
http://www.biomedcentral.com/1471-2407/14/236
van Muijen et al. BMC Cancer 2014, 14:236 Page 8 of 10
http://www.biomedcentral.com/1471-2407/14/236to life time best (WAI) (OR 0.09; CI 0.04-0.19) was asso-
ciated with a decreased risk for work disability.
Discussion
Main findings
The aim of this study was to identify determinants asso-
ciated with work disability defined as wage loss related to
functional limitations, at 24-month sick leave in cancer
survivors. For cancer survivors at 24 months of sick leave,
Dutch nationality, higher education, hormone therapy,
metastatic disease, a high physical dimension score (SIP)
and low current work ability, compared to life time best
score (WAI), were associated with an increased risk for
work disability.
Interpretation of the findings and comparison with other
studies
In this study, we found that higher education (at the level
of secondary school and vocational education/upper sec-
ondary school) was associated with an increased risk for
work disability. This result differs from previous studies,
possibly due to the specific legislation applied in the
Netherlands, in which work disability not only relates to
limitations and loss of functional abilities, but to wage loss
as well. As a consequence, if less paid jobs are associated
with a low educational level, then it is likely that on assess-
ment of work disability, a low educated cancer survivor
suffers only little wage loss. That is, a low educated cancer
survivor still able to work and earn a major part of the
previous income is less likely to be granted a disability
benefit. The mechanism involved could also relate to the
presence of disease induced disabilities and limitations,
making it harder to meet the cognitive job demands of the
better educated white collar workers. As a consequence,
higher educated white collar workers face wage loss, as
only less complex and consequently less paid jobs meet
their remaining abilities. The suggested mechanism men-
tioned above agrees with the findings of previous studies,
which have reported long-term negative effects of diagno-
sis and treatment on the ability to memorize, concentrate,
direct attention and solve problems [35-37]. The results of
previous studies indicate that in cancer survivors a low
educational level is negatively associated with work par-
ticipation. This in turn calls for a policy in order to sup-
port these workers in their vocational rehabilitation.
We also found that workers of non-Dutch nationality
had a decreased risk for work disability. This finding
must be interpreted with caution and may be due to
coincidence, considering the small number of these
workers in our study (n = 11).
Also, we found that receiving hormone therapy was
associated with an increased risk for work disability. In
breast cancer survivors, this could be due to the oc-
currence of treatment induced menopausal symptoms,resulting from hormone therapy, that may have a nega-
tive impact on cognitive tasks and/or social and emo-
tional aspects of work ability [38]. Our findings indicate
that side effects of hormone therapy should not be
underestimated and suggest that risk for work disability
at 24-month sick leave may be reduced if at the start of
hormone therapy attention is given to possible side ef-
fects of treatment. That is, job and workplace accommo-
dations and offering alternative tasks may support those
suffering from side effects of hormone therapy and may
facilitate work participation.
Cancer survivors with metastatic disease had an in-
creased risk for work disability. This finding concurs
with previous studies that describe the negative relation-
ship between the extensiveness/burden of disease and
work ability [39-42]. Metastatic disease and a related
poor health condition, due to symptoms such as fatigue,
combined with negative side-effects of ongoing treat-
ment may limit functional abilities. Symptoms associated
with metastatic disease may add up to such an extent
that even activities of daily living are difficult to meet
and work participation is not possible [43].
Related to the SIP, we found that as the number of
limitations in the physical domain of the SIP increases,
the risk for work disability increases as well. Our finding
concurs with the results of a previous study on cancer
survivors (mixed diagnoses) and work disability, which
indicated that survivors were leaving the labour force or
were functioning less fully at work than before becoming
ill [44]. In this study, the strongest predictors of work
disability were physical dysfunction, measured by the
SIP, and disease stage.
Finally, in our sample of cancer survivors, a high score
on work ability (WAI current) was associated with a re-
duced risk for work disability. This finding agrees with the
results of a previous study in which work ability assessed
at six months sick leave (using the WAI) strongly pre-
dicted RTW at 18 months [25]. Therefore, considering
our findings, it is possible that during sustained sick leave,
measurement of self-assessed work ability at fixed inter-
vals may also be helpful to identify cancer survivors at risk
for work disability after a period of 24-month sick leave.
Strengths and limitations
A strength of our study is that the sample was drawn from
the entire Dutch working population. Another strength is
that the primary outcome of the study was not self re-
ported but based on the assessment by an independent in-
surance physician and a labour expert, following uniform
guidelines, based on national legislation being practised at
all SSA offices nationwide. This warrants a uniform pro-
cedure by which work disability is judged. However, in
assessing functional abilities of workers, insurance phy-
sicians use a standardized List of Functional Abilities
van Muijen et al. BMC Cancer 2014, 14:236 Page 9 of 10
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previous study on work disability assessments found small
to moderate systematic variations in the outcome of work
disability assessments related to inter-doctor variations,
which can be considered a limitation of the present study
[46]. Another limitation of the study is its cross-sectional
design, which makes it impossible to disclose causal rela-
tionships. Also, the study results relate to Dutch social se-
curity legislation, in which functional limitations and wage
loss define the level of work disability. This impedes the
generalisation to workers in other countries.
Practical implications
Work participation of cancer survivors may be en-
hanced if factors hindering this process are identified
and open to change or otherwise given attention in a
supportive way. This study identified six factors associ-
ated with work disability of employed cancer survivors
at 24-month sick leave. The association of nationality
with work disability needs further clarification, consi-
dering the small number of respondents in our study of
non-Dutch nationality. For future studies, a policy to
sample a sufficient number of workers of non-Dutch na-
tionality is advised. The level of former education may
also help to identify sick listed workers at risk for work
disability and, though educational level may not be
changed easily, vocational training and courses that
focus on acquiring new skills may support sick listed
cancer survivors and enhance their work participation.
Caregivers involved in vocational rehabilitation must be
aware of possible long-term impact of hormone therapy
on work disability, encourage cancer survivors to reveal
and discuss possible side effects of hormone therapy
and advise measures to cope with these, preferably at
the start of therapy. The presence of metastatic disease
is a factor unlikely to change, but to caregivers involved,
this aspect may serve as a warning sign and draw atten-
tion to individuals at risk for work disability. Likewise,
monitoring of physical limitations during prolonged sick
leave may help to identify those at risk for work dis-
ability. In cancer survivors apt to rehabilitation, these
limitations could possibly diminish with the use of tai-
lored interventions that may reduce the risk for work
disability. The data suggest that, considering the results
of a previous study on repeated work ability scores [25],
monitoring self-assessed work ability scores during sus-
tained sick leave, may support the identification of can-
cer survivors at risk for work disability at 24-month sick
leave. For a part, our results may also apply to cancer
survivors abroad. Therefore, in the European context,
further research on long term effects of hormone the-
rapy, the survey of physical limitations and use of self-
assessed work ability in identifying cancer survivors at
risk for work disability, is suggested.Conclusions
The results of the current study may serve as a starting
point to investigate the course of work disability beyond
the 24-month sick leave term. In order to enhance work
participation of cancer survivors beyond this term, pro-
spective data on work disability are required and called
for.
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